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the results of real time PCR and western blot demonstrated that
captopril signiﬁcantly downregulated the expression of apamin sen-
sitive SK channels (SK3 mRNA: CAF 2.10  0.9, n ¼ 6 vs HF 8.40  2.10,
n ¼ 6; SK3 protein: CAF 0.40  0.07, n ¼ 6 vs HF 0.56  0.09, n ¼ 6).
CONCLUSIONS Captopril signiﬁcantly downregulated the sensitivity
of SK channels to [Ca2þ]i and the SK3 channels expression in HF, and
reversed the SK channels remodeling.GW26-e1586
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OBJECTIVES AMP-activated protein kinase (AMPK) exerts inhibitory
effects on cardiac hypertrophy. However, the mechanism remains
unclear. The aim of the present study was to investigate the effects of
AMPK on angiotensin II (AngII) -induced proliferation of cardiac
ﬁbroblast and the mechanisms involved.
METHODS Proliferation of cardiac ﬁbroblast was induced by angio-
tensin II (AngII). Cardiac ﬁbroblasts were treated with the speciﬁc
AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside
(AICAR, 0.5 mmol/L) and the speciﬁc AMPK antagonist Compound C
(1 umol/L), and then stimulated with AngII (1 umol/L). Cell prolifera-
tion and the DNA synthesis were measured by MTT assay and EdU
incorporation assay. TGF-b1 and Smad2, 3, 4 mRNA and protein
expression was detected using Real-Time PCR and western blot
analysis.
RESULTS Activation of AMPK by AICAR could inhibit AngII-induced
proliferation of cardiac ﬁbroblasts, manifesting decreased DNA syn-
thesis and collagen production (P<0.05). Moreover, AngII signiﬁ-
cantly increased the mRNA and protein expression of TGF-b1 and
Smad2, 3, 4 (P<0.05). AMPK activation markedly reversed the
elevated TGF-b1 and Smad2, 3, 4 mRNA and protein levels (P<0.05).
Furthermore, Treatment of proliferated cardiac ﬁbroblasts with
Compound C blunted the effects of AMPK on proliferation of cardiac
ﬁbroblasts and changes to the TGF-b1/Smad pathway (P<0.05).
CONCLUSIONS AMPK activation could attenuate proliferation of
cardiac ﬁbroblast induced by AngII, which may be due to the inhibi-
tion of TGF-b1/Smad pathways.GW26-e4768
Improved Recovery After Myocardial Ischemic Infarction by Copper
Supplementation
Pengfei Han,1 Xiang Zhou,1 Wenjing Zhang,1 Qipu Feng,1 Ying Xiao,1
Xiaorong Sun,1 Xinmei Zhao,1 Haiying Fu,1 Y. James Kang1,2
1Regenerative Medicine Research Center, West China Hospital, Sichuan
University, Chengdu, Sichuan, China; 2Department of Pharmacology
and Toxicology, University of Louisville School of Medicine, Louisville,
Kentucky, USA
OBJECTIVES Depressed angiogenesis due to ischemic injury leads to
myocardial infarction. Copper (Cu) is involved in angiogenesis and
ischemia causes copper loss in the heart. The present study was un-
dertaken to test the hypothesis that Cu supplementation improves
myocardial angiogenesis, leading to regression of myocardial ischemic
infarction in Rhesus monkey model.
METHODS Coronary artery ligation was used to produce myocardial
ischemia and the monkeys developed myocardial infarction 4 weeks
after ischemia. A newly developed ultrasound contrast microbubble
composed of Cu-albumin coated structure was used to speciﬁcally
deliver Cu into the infarct area. The treatment was performed twice a
week for 4 weeks.
RESULTS This procedure effectively increased Cu concentrations in
the infarct area and activated the angiogenesis factors including
vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1),
and other relevant factors. Along with these changes, myocardial
infarct size was signiﬁcantly decreased and the density of myocardial
microvessels was signiﬁcantly increased. In addition, cardiac function
was signiﬁcantly recovered, as evidenced by increased ejection fraction
(EF) values and decreased end-systolic volume (ESV) measured by
echocardiography.CONCLUSIONS This study thus demonstrated that Cu supplementa-
tion improved cardiac structural and functional recovery after
ischemic infarction.
Supported by National Science Foundation of China (81230004 and
81300109).
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Discovery of a new conduction substrate associated with atrioventricular
node-anterior extension pathway
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OBJECTIVES The atrioventricular node(AVN) plays a role in conducting
action potentials at an appropriate conduction velocity from atria to
ventricles. Its complex anatomical structures and functional longitudi-
nal dissociations are considered important in delayed conduction and
AVN reentrant tachycardia (AVNRT). Inferior nodal extensions(INE) are
part of the AVN. It is thought that these extensions may be involved in
slow-pathway conduction and are part of the underlying circuitry that
causes AVNRT. Some other conduction tissue shared the same origin
layers with AVN distribute around the two valve annulus. The retro-
aortic node deﬁned as the enlargement of this node-like tissue is located
on the right side of the atrium parallel with the aorta. The potential
electrophysiological function of these node-like tissues is still unknown.
Understanding their detail anatomical structure, histological features
and electrophysiological behavior are signiﬁcant to clear the complex
conduction characteristics of the AV junction.
METHODS Adult rats(n¼6), mice(n¼5) and rabbit(n¼5) were used.
Serial sections from the entire AV junction were obtained. Masson’s
trichrome stain was performed on AVN regions to assess for ﬁbrous
tissue. Three connexins(Cx) proteins including Cx43, Cx40 and Cx45
which dominate the electronic conduction of the heart and three main
ion channels(Nav1.5, Cav3.1 and HCN4) participating the depolariza-
tion of myocardial cell were immunohistochemically labeled. Serial
sections were used to reconstruct a 3D computational model of the
anatomy of the AV junction which display the different histological
features at different levels.
RESULTS There appears to be an anterior extension of the AVN which
connect retroaortic node and AVN. The anterior node extension
(ANE), compact node and INE express the same connexin isoforms.
Nav1.5 labeling was abundant in the atrial and ventricular myocar-
dium. Nav1.5 labeling presents at a reduced level in the compact node,
ANE and INE. Cav3.1 and HCN4 expression were mainly expressed in
the Nav1.5 reduced area. Further, connections between the atria and
inferior extension occur indirectly via small branches. However, this
was distinct from the connection pattern that we observed between
the atria and ANE, which was direct.
CONCLUSIONS We conclude that the retroaortic node connect with
ANE forming ANE which suggests there would be direct electric con-
duction between them. Characteristics of these structures are
conserved among various species including rat, mouse and rabbit as
we had proven. ANE, AVN and INE have nearly the same electronic
level and action potential level structure basic that highlight they
would have the same conduction properties, but there are different
connection patterns in atrium between them that suggests there
would be the subtle conduction velocity difference after accept the
impulse, which provide a new location and substrate of conduction
that may present new insights on mechanisms underlying normal AV
conduction and AVNRT.
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OBJECTIVES AVE 0991, the nonpeptide angiotensin-(1-7) (Ang-(1-7))
analog, is recognized as having beneﬁcial cardiovascular effects.
However, the mechanisms have not been fully elucidated. This study
was designed to investigate the effects of AVE 0991 on cardiac hy-
pertrophy and the mechanisms involved.
METHODS Mice were subjected to aortic banding (AB) to induce cardiac
hypertrophy. After treatment with AVE 0991 (20 mg$kg$day (-1)) for four
weeks, indices of cardiac hypertrophy and heart function were
measured by echocardiography, histological analyses and quantitative
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protein expression of left ventricular tissues was detected using q-PCR
and western blot analysis that are associated with oxidative stress.
RESULTS AVE 0991 displayed a signiﬁcant reduction in the left ven-
tricular weight (15.960.68 vs. 22.210.75, P < 0.01) and left ventric-
ular end-diastolic diameter (3.480.19 vs. 4.320.20, P < 0.05), and a
signiﬁcant elevation in left ventricular ejection fraction (58.162.78
vs. 41.825.58, P < 0.05) when compared to the vehicle-treated AB
group. Moreover, we found that the mean myocyte diameter (13.53
0.56 vs. 15.46  0.21, P < 0.01) and the gene expression of the hy-
pertrophic markers atrial natriuretic peptide (ANP) (P < 0.01) and b-
MHC (P < 0.01) were markedly decreased in the AVE0991 group.
Furthermore, AVE 0991 inhibited the mRNA and protein expression of
NOX 2 (P < 0.01) and NOX 4 (P < 0.01) when compared to the vehicle-
treated AB group.
CONCLUSIONS Our data showed that AVE 0991 treatment could
attenuate cardiac hypertrophy and improve heart function, which
may be attributed to reducing the oxidative stress.
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OBJECTIVES Maternal nicotine exposure caused alteration of gene
expression patterns and programming of cardiovascular dysfunction.
This study was to investigate effect of nicotine on cardiac gene
expression and epigenetic regulation during cardiac myogenesis.
METHODS To study effect of nicotine on cardiac myogenesis, in vitro
and in vivo cardiac developmental model were established respec-
tively. Mouse embryonic bodies (EBs) derived from mouse embryonic
stem cells were induced to 12-day cardiac differentiation with or
without nicotine treatment. As in vivo cardiac myogenic model,
pregnant Sprague–Dawley rats were exposed to nicotine through
gestation, hearts were isolated from neonatal offspring for further
molecular study after echocardiography for heart function.
RESULTS In vitro study shows nicotine exposure selectively inhibited
expression of two cardiac genes (GATA4 and Tbx5) in both mRNA and
protein expression level. Persistent nicotine exposure resulted in up-
regulation of 5-methylcytosine, DNMT1 and DNMT3A but decreased
GATA4 and Tbx5 gene expression due to promoter DNA hypermethylation.
However, no signiﬁcant effect has been found on mESCs proliferation and
two embryonic biomarkers’(Oct4 and Nanog) mRNA expression with
nicotine treatment. Nicotine exposure also decreased amounts of beating
EBs and reduced GATA4 positive cells at 12-day EBs. This nicotine-induced
suppression was reversed by general nicotinic acetylcholine receptors
(nAChRs) inhibitor, suggesting the involvement of nAChRs in the direct
adverse impact of nicotine on cardiac differentiation. Consistent results of
GATA4 and Tbx5 gene suppression and promoter DNA hypermethylation
by maternal nicotine treatment were obtained from in vivo cardiac
development model. Echocardiography showed impaired cardiac function
in offspring including reduced ejection fraction (EF%), systolic and dia-
stolic left ventricular anterolateral wall (LVAW;s and LVAW;d) as well as
systolic and diastolic left ventricular posterior wall (LVPW;s and LVPW;d).
CONCLUSIONS This study presents a direct repressive effect of
nicotine on cardiac transcriptional factors (GATA4 and Tbx5) by pro-
moter DNA hypermethylation during cardiac myogenesis. Reduction
of spontaneous beating EBs and impaired cardiac function in offspring
heart has been found with nicotine exposure.
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OBJECTIVES Timothy syndrome (TS) is a malignant form of congen-
ital long QT syndrome with excessive cellular Ca2þ entry and torsadede pointes (TdP) arrhythmias often triggered by a variety of neuro-
hormonal and second-massager pathways. We sought to explore
mechanisms by which Ca2þ/ calmodulin-dependent protein kinase
(CaMKII) modulates arrhythmogenesis and to identify potential tar-
geted sites of antiarrhythmic therapy in TS arising from a novel mu-
tation (CACNA1C, p.G1911R).
METHODS A 15 mm15 mm two-dimensional (2D) multicellular
transmural tissue model was developed by integrating an anatomi-
cally ventricular geometry of the human ventricular tissue sheet and a
dynamic human ventricular myocyte model incorporated with a
detailed CaMKII module in the format of mono-domain model. To
better understand the TS, L-type Ca2þ current (ICaL) equations of the
myocyte model were modiﬁed based on experimental conditions
(current density increasedw20%, V1/2 of activation shiftedw-5mV, V1/2
of inactivation shifted wþ6 mV, tau of inactivation increased w20%).
To explore ionic mechanisms of CaMKII-dependent TdP, proar-
rhythmic substrates were compared and analyzed. In addition, in
order to investigate mechanisms initiating and maintaining TdP, the
spatial organization of repolarization and arrhythmogenesis were
determined in the 2D transmural tissue model.
RESULTS TS ventricular myocytes exhibited more activated
CaMKII(w50%), increased ICaL facilitation (w55%), higher peak Ca2þ
transient (w83%), augmented frequency of Ca2þ sparks (w200%),
enhanced maximum SR Ca2þ content (w34%), prolonged action po-
tential duration (APD) and afterdepolarizations. On the one hand,
CaMKII-dependent SR overload resulted in SR Ca2þ leak for triggering
delayed afterdepolarizations (DADs); on the other hand, CaMKII-
dependent ICaL facilitation contributed to excessive action potential
prolongation in midmyocardial (M) cells (from 413.6 to 1133.9 ms)
which favors the generation of early afterdepolarizations(EADs). The
excessive prolongation of APD in the M cells caused an abrupt rise in
transmural dispersion of repolarization (from 33.06 ms/mm to 52.99
ms/mm) and M cells formed zones of increased refractoriness, pro-
ducing steep spatial gradients of repolarization that were directly
responsible for conduction block and self-sustained intramural reen-
trant circuits underlying TdP. However, CaMKII inhibition reversed
an increase in intracellular Ca2þ, normalized action potential and
prevented TdP.
CONCLUSIONS These computer simulations suggest that TS-medi-
ated Ca2þ inﬂux is an upstream initiating event for arrhythmia phe-
notypes that are ultimately dependent on CaMKII activation, the M
region of TS can increase intrinsic heterogeneities of cardiac tissue
and resulte in the generation and maintenance of reentrant excita-
tions underlying TdP, and CaMKII blockers may provide additional
antiarrhythmic effect in patients with TS.GW26-e4017
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OBJECTIVES Drag-reducing polymers (DRPs) are blood-soluble mac-
romolecules that can increase blood ﬂow and reduce vascular resis-
tance. It has been widely used in petroleum transportation, irrigation,
navigation and other industrial pipeline. In recent years, the potential
medical application of DRPs had been explored in cardiovascular
disease, atherosclerosis, shock and other ﬁelds. The purpose of the
present study is to observe the effect of DRPs on myocardial ischemia/
reperfusion (I/R) injury in rat model.
METHODS Adult Wistar rats were randomly divided into three groups
(n¼16): DRP group, Control group and Sham group. Acute myocardial
infarction achieved by occluding left anterior descending coronary
artery (LAD). After 30 min of ischemia, the LAD was released 120 min
to induce I/R injury. Sham animals underwent left thoracotomy only.
Rats in DRP group were injected with 510-5 g/ml DRP solution
through the right jugular vein at a constant rate of 3.5 ml/h for 30 min
during reperfusion. Saline was administered in control group and
sham group. Ejection fraction was measured by echocardiography
after 120 min reperfusion. A catheter inserted into left ventricle to
measure left ventricular systolic pressure (LVSP) and left ventricular
end-diastolic pressure (LVEDP). Myocardial infarct size were also been
measured.
RESULTS All rats in sham group survived through 150 min observa-
tion period, the survival rate in DRP group was 81.25% (13/16),
